Calamos Advisors’s Tevogen Bio Holdings TVGN Stock Holding History

Calamos Advisors’s Portfolio TVGN Stock Details TVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-40,000	Closed	-$20.7M	–	1217
2022 Q4	$20.7M	Buy	+40,000	New	+$20.5M	0.1%	256

Other funds holding TVGN

CCP

Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return

FCM

FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Calamos Advisors's TVGN Position: Q1 2023 in Review

Calamos Advisors sold out of Tevogen Bio Holdings (TVGN) in Q1 2023, closing a stake of 40,000 shares — an estimated $20.7M sold.

Calamos Advisors first reported a position in TVGN in Q4 2022 and held it in 1 quarter. The position peaked at $20.7M in Q4 2022. 4 funds tracked by Wall St. Rank hold TVGN as of Q1 2023.

Calamos Advisors reported no remaining Tevogen Bio Holdings position as of Q1 2023 after selling out during the quarter.
Calamos Advisors sold 40,000 Tevogen Bio Holdings shares in Q1 2023, an estimated $20.7M.
Calamos Advisors first reported a position in Tevogen Bio Holdings in Q4 2022 and held it in 1 quarter.
Calamos Advisors's Tevogen Bio Holdings position peaked at $20.7M in Q4 2022.
4 funds tracked by Wall St. Rank held Tevogen Bio Holdings as of Q1 2023.

Based on Calamos Advisors's 13F filing for Q1 2023, filed 4 May 2023.